AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27555173 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender fleur oil (LFO) aromatherapy
Number of subjects: 93
Study 27555173 — intervention group
Group type: COMPARATOR
Intervention: Unscented oil (UO) aromatherapy
Number of subjects: 93
Study 27555173 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LFO and UO aromatherapy
Number of subjects: 93
Study 24989688 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent allergic rhinitis (AR)
Number of subjects: 80
Study 24989688 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonallergic rhinitis with eosinophilia syndrome (NARES)
Number of subjects: 80
Study 24989688 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic rhinosinusitis with polyps (CRSwNP)
Number of subjects: 80
Study 24989688 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between CCL24 and CCL26 levels
Number of subjects: 80
Study 24989688 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-rhinitic volunteers)
Number of subjects: 80
Study 22926279 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific trunk exercise group (SEG)
Number of subjects: 64
Study 22926279 — intervention group
Group type: COMPARATOR
Intervention: General exercise group (Control)
Number of subjects: 64
Study 22926279 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 64
Study 20642710 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins (atorvastatin 10 mg, atorvastatin 80 mg, pravastatin 40 mg/day)
Number of subjects: 424
Study 20642710 — intervention group
Group type: COMPARATOR
Intervention: Control (no statins)
Number of subjects: 424
Study 17644475 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal CPAP with standard prenatal care
Number of subjects: 16
Study 17644475 — intervention group
Group type: COMPARATOR
Intervention: Standard prenatal care alone
Number of subjects: 16
Study 16131799 — intervention group
Group type: EXPERIMENTAL
Intervention: ZK 200775 (525 mg in 48 h)
Number of subjects: 61
Study 16131799 — intervention group
Group type: EXPERIMENTAL
Intervention: ZK 200775 (105 mg over 6 h)
Number of subjects: 61
Study 16131799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 12368893 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyract (compomer)
Number of subjects: 60
Study 12368893 — intervention group
Group type: COMPARATOR
Intervention: Amalgam (Contour)
Number of subjects: 60
Study 10628893 — intervention group
Group type: EXPERIMENTAL
Intervention: INN 00835 (0.2 mg/kg, subcutaneously, once daily for 5 days)
Number of subjects: 35
Study 10628893 — intervention group
Group type: COMPARATOR
Intervention: Placebo (subcutaneously, once daily for 5 days)
Number of subjects: 35
Study 7606653 — intervention group
Group type: EXPERIMENTAL
Intervention: Group counselling session (1.5-2.0 hours)
Number of subjects: 164
Study 7606653 — intervention group
Group type: COMPARATOR
Intervention: Information pamphlet
Number of subjects: 164
Study 2205121 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger root
Number of subjects: 60
Study 2205121 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 60
Study 2205121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 384241 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (10 g per day)
Number of subjects: 150
Study 384241 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 150
Study 384241 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 150
Study 30255369 — intervention group
Group type: COMPARATOR
Intervention: Conventional knee unloader brace (Unloader One®)
Number of subjects: 160
Study 30255369 — intervention group
Group type: EXPERIMENTAL
Intervention: New knee OA ankle brace (Agilium FreeStep®)
Number of subjects: 160
Study 29021286 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate juice
Number of subjects: 16
Study 29021286 — intervention group
Group type: COMPARATOR
Intervention: Control solution containing equivalent amount of sugars
Number of subjects: 16
Study 29021286 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate polyphenol-rich extract (supplement)
Number of subjects: 16
Study 29021286 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution containing malic and citric acid components
Number of subjects: 16
Study 26338890 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa beverage (960 mg total polyphenols; 480 mg flavanols)
Number of subjects: 18
Study 26338890 — intervention group
Group type: COMPARATOR
Intervention: Flavanol-free placebo (110 mg total polyphenols; <0.1 mg flavanols)
Number of subjects: 18
Study 23670706 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment (n=28)
Number of subjects: 60
Study 23670706 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lithium treatment, n=32)
Number of subjects: 60
Study 21516368 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-miss outcomes during personal choice trials
Number of subjects: 33
Study 21516368 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-miss outcomes
Number of subjects: 33
Study 21516368 — intervention group
Group type: EXPERIMENTAL
Intervention: Winning outcomes
Number of subjects: 33
Study 21516368 — intervention group
Group type: COMPARATOR
Intervention: Full-misses
Number of subjects: 33
Study 18976879 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-weighing at least weekly
Number of subjects: 100
Study 18976879 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-weighing
Number of subjects: 100
Study 18976879 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight-loss program with telephone counseling, written manual, and home telemonitoring scale
Number of subjects: 100
Study 17974175 — intervention group
Group type: EXPERIMENTAL
Intervention: Prelox
Number of subjects: 50
Study 17974175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 15364747 — intervention group
Group type: EXPERIMENTAL
Intervention: IV amiodarone (0.73 mg/min for 48 hours) followed by oral amiodarone (400 mg q12h for 3 days)
Number of subjects: 51
Study 15364747 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical therapy (control group)
Number of subjects: 51
Study 15364747 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone group
Number of subjects: 51
Study 15364747 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study 10743904 — intervention group
Group type: EXPERIMENTAL
Intervention: Commonly prescribed analgesic medications
Number of subjects: 0
Study 10743904 — intervention group
Group type: EXPERIMENTAL
Intervention: UV-induced hyperalgesia model
Number of subjects: 0
Study 10743904 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant-rated measures of drug liking and mood
Number of subjects: 0
Study 8957598 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise testing in patients with CHF
Number of subjects: 35
Study 8957598 — intervention group
Group type: COMPARATOR
Intervention: Cardiopulmonary exercise testing in healthy subjects
Number of subjects: 35
Study 8245113 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based burn treatment modality
Number of subjects: 0
Study 8245113 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 2951012 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 0
Study 2951012 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen with codeine
Number of subjects: 0
Study 29615049 — intervention group
Group type: EXPERIMENTAL
Intervention: SB010 (10 mg bid for 28 days)
Number of subjects: 23
Study 29615049 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 29615049 — intervention group
Group type: EXPERIMENTAL
Intervention: SB010
Number of subjects: 23
Study 29615049 — intervention group
Group type: COMPARATOR
Intervention: SB010 and Placebo
Number of subjects: 23
Study 28488042 — intervention group
Group type: EXPERIMENTAL
Intervention: Licener® (neem extract shampoo); treated on day 1 and day 9.
Number of subjects: 119
Study 28488042 — intervention group
Group type: COMPARATOR
Intervention: Jacutin® Pedicul Fluid (dimethicone); treated on day 1 and day 9.
Number of subjects: 119
Study 28488042 — intervention group
Group type: COMPARATOR
Intervention: Combined success rate of Licener® vs Jacutin®.
Number of subjects: 119
Study 28488042 — intervention group
Group type: COMPARATOR
Intervention: Licener® vs Jacutin® in terms of ovicidal efficacy.
Number of subjects: 119
Study 24197517 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma Desensitizer (Heraeus)
Number of subjects: 27
Study 24197517 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-power laser at low dose (30 mW, 10 J/cm², 9 s per point, 810 nm)
Number of subjects: 27
Study 24197517 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-power laser at high dose (100 mW, 90 J/cm², 11 s per point, 810 nm)
Number of subjects: 27
Study 24197517 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-power laser at low dose + Gluma Desensitizer
Number of subjects: 27
Study 24197517 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-power laser at high dose + Gluma Desensitizer
Number of subjects: 27
Study 23279603 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 30
Study 23279603 — intervention group
Group type: COMPARATOR
Intervention: Hypocaloric diet
Number of subjects: 30
Study 21568831 — intervention group
Group type: EXPERIMENTAL
Intervention: Handling strategies
Number of subjects: 37
Study 21568831 — intervention group
Group type: EXPERIMENTAL
Intervention: Handling strategies + specific strength exercises
Number of subjects: 37
Study 21568831 — intervention group
Group type: EXPERIMENTAL
Intervention: Handling strategies + specific strength exercises + weekly physiotherapist training
Number of subjects: 37
Study 21568831 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 37
Study 19309586 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy group (methylprednisolone, cyclophosphamide, Etanercept)
Number of subjects: 136
Study 19309586 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy group
Number of subjects: 136
Study 19309586 — intervention group
Group type: COMPARATOR
Intervention: Normal therapy group
Number of subjects: 136
Study 16522386 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate initiation of epidural analgesia at first request (221 women)
Number of subjects: 449
Study 16522386 — intervention group
Group type: COMPARATOR
Intervention: Delay of epidural until cervix dilated to at least 4 cm (228 women)
Number of subjects: 449
Study 16522386 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate initiation of epidural analgesia
Number of subjects: 449
Study 16522386 — intervention group
Group type: COMPARATOR
Intervention: Delay of epidural
Number of subjects: 449
Study 12945019 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative epidural analgesia (EA)
Number of subjects: 1000
Study 12945019 — intervention group
Group type: COMPARATOR
Intervention: No postoperative epidural analgesia (no EA)
Number of subjects: 1000
Study 11098042 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic myomectomy
Number of subjects: 131
Study 11098042 — intervention group
Group type: COMPARATOR
Intervention: Abdominal myomectomy
Number of subjects: 131
Study 9526601 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 micrograms fentanyl (F group)
Number of subjects: 60
Study 9526601 — intervention group
Group type: COMPARATOR
Intervention: 3 ml normal saline (N/S group)
Number of subjects: 60
Study 9526601 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg tenoxicam (T group)
Number of subjects: 60
Study 1286128 — intervention group
Group type: EXPERIMENTAL
Intervention: TTPG 180 mg
Number of subjects: 12
Study 1286128 — intervention group
Group type: EXPERIMENTAL
Intervention: TTPG 540 mg
Number of subjects: 12
Study 1286128 — intervention group
Group type: EXPERIMENTAL
Intervention: TTPG 1080 mg
Number of subjects: 12
Study 1286128 — intervention group
Group type: EXPERIMENTAL
Intervention: TCA 180 mg
Number of subjects: 12
Study 1286128 — intervention group
Group type: EXPERIMENTAL
Intervention: TCA 540 mg
Number of subjects: 12
Study 1286128 — intervention group
Group type: EXPERIMENTAL
Intervention: TCA 1080 mg
Number of subjects: 12
Study 1286128 — intervention group
Group type: EXPERIMENTAL
Intervention: tiopronin 180 mg
Number of subjects: 12
Study 1286128 — intervention group
Group type: EXPERIMENTAL
Intervention: tiopronin 540 mg
Number of subjects: 12
Study 1286128 — intervention group
Group type: EXPERIMENTAL
Intervention: tiopronin 1080 mg
Number of subjects: 12
Study 3936869 — intervention group
Group type: EXPERIMENTAL
Intervention: NAAGA eye-drops
Number of subjects: 50
Study 3936869 — intervention group
Group type: COMPARATOR
Intervention: Disodium Cromoglycate eye-drops
Number of subjects: 50
Study 3936869 — intervention group
Group type: EXPERIMENTAL
Intervention: NAAGA after Cromoglycate
Number of subjects: 50
Study 3936869 — intervention group
Group type: COMPARATOR
Intervention: Disodium Cromoglycate after NAAGA
Number of subjects: 50
Study 31163259 — intervention group
Group type: EXPERIMENTAL
Intervention: PCforMe (Palliative Care for Me)
Number of subjects: 80
Study 31163259 — intervention group
Group type: COMPARATOR
Intervention: Control group (three common online resources)
Number of subjects: 80
Study 29090731 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadaver group
Number of subjects: 31
Study 29090731 — intervention group
Group type: COMPARATOR
Intervention: Manikin group
Number of subjects: 31
Study 29090731 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 31
Study 27075276 — intervention group
Group type: EXPERIMENTAL
Intervention: Equine neck model for training
Number of subjects: 93
Study 24325305 — intervention group
Group type: EXPERIMENTAL
Intervention: Tac (tacrolimus)
Number of subjects: 95
Study 24325305 — intervention group
Group type: COMPARATOR
Intervention: CsA (cyclosporine)
Number of subjects: 95
Study 23748259 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of gustatory disorders in patients with olfactory dysfunction
Number of subjects: 140
Study 23748259 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory dysfunction causes
Number of subjects: 140
Study 20647644 — intervention group
Group type: EXPERIMENTAL
Intervention: OCD-algorithm
Number of subjects: 53
Study 20647644 — intervention group
Group type: COMPARATOR
Intervention: Reported-algorithm
Number of subjects: 53
Study 18029343 — intervention group
Group type: EXPERIMENTAL
Intervention: Preimplantation genetic screening (PGS)
Number of subjects: 0
Study 18029343 — intervention group
Group type: COMPARATOR
Intervention: Control group without PGS
Number of subjects: 0
Study 16912706 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 25
Study 16912706 — intervention group
Group type: COMPARATOR
Intervention: Control (current immunosuppressive treatment)
Number of subjects: 25
Study 16912706 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus (in patients with proteinuria)
Number of subjects: 25
Study 14671148 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegvisomant-induced serum IGF-I normalization
Number of subjects: 16
Study 10951338 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine 1250 mg/m² and vinorelbine 25 mg/m² administered on Days 1 and 8 every 3 weeks for up to 9 courses
Number of subjects: 54
Study 10951338 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus vinorelbine
Number of subjects: 54
Study 7941897 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant intramuscular immunoglobulin against tick‐borne encephalitis
Number of subjects: 115
Study 7941897 — intervention group
Group type: COMPARATOR
Intervention: Nonspecific treatment alone
Number of subjects: 115
Study 2895840 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg twice a day
Number of subjects: 131
Study 2895840 — intervention group
Group type: COMPARATOR
Intervention: 200 mg four times a day
Number of subjects: 131
Study 2895840 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg once a day
Number of subjects: 131
Study 2895840 — intervention group
Group type: COMPARATOR
Intervention: Before treatment
Number of subjects: 131
Study 2895840 — intervention group
Group type: EXPERIMENTAL
Intervention: During treatment
Number of subjects: 131
Study 2895840 — intervention group
Group type: EXPERIMENTAL
Intervention: After stopping treatment
Number of subjects: 131
Study 29730907 — intervention group
Group type: EXPERIMENTAL
Intervention: Iso‐Tome® precut (IT‐P)
Number of subjects: 239
Study 29730907 — intervention group
Group type: COMPARATOR
Intervention: Needle‐knife precut fistulotomy (NK‐F)
Number of subjects: 239
Study 28666335 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger 160 mg/day
Number of subjects: 244
Study 28666335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study 23812286 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic surgery (SILS)
Number of subjects: 60
Study 23812286 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible single-incision surgery (FSIS)
Number of subjects: 60
Study 23812286 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopy (CL)
Number of subjects: 60
Study 21088973 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-vigorous resistance exercise (M-VR)
Number of subjects: 12
Study 21088973 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity aerobic exercise (LA)
Number of subjects: 12
Study 21088973 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-vigorous aerobic exercise (M-VA)
Number of subjects: 12
Study 21088973 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity resistance exercise (LR)
Number of subjects: 12
Study 19298585 — intervention group
Group type: EXPERIMENTAL
Intervention: TZP-101 (80, 160, 320 or 600 microg/kg)
Number of subjects: 10
Study 19298585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 17951928 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine and sodium fluoride mouthrinse
Number of subjects: 0
Study 17951928 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine mouthrinse alone
Number of subjects: 0
Study 14980746 — intervention group
Group type: COMPARATOR
Intervention: risperidone
Number of subjects: 5
Study 11513305 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold dive to 50 m
Number of subjects: 26
Study 11513305 — intervention group
Group type: COMPARATOR
Intervention: Comfortable temperature dive to 50 m
Number of subjects: 26
Study 11513305 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold dive to 10 m
Number of subjects: 26
Study 9773132 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 2.5 mg/ml
Number of subjects: 24
Study 9773132 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 2.5 mg/ml
Number of subjects: 24
Study 9773132 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ropivacaine and bupivacaine
Number of subjects: 24
Study 8582131 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (2 x 850 mg day-1 for 2 days and 850 mg 1 h before evaluation)
Number of subjects: 15
Study 8582131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 1967226 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil (Ro 15‐1788)
Number of subjects: 40
Study 1967226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 645073 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone (20 mg per kg body weight i.v.)
Number of subjects: 16
Study 645073 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 16
Study 645073 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 16
Study 645073 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal stimulation
Number of subjects: 16
Study 31418515 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation
Number of subjects: 0
Study 31418515 — intervention group
Group type: COMPARATOR
Intervention: Centre-based pulmonary rehabilitation
Number of subjects: 0
Study 30967135 — intervention group
Group type: EXPERIMENTAL
Intervention: Class II compression stockings (23‐32 mmHg)
Number of subjects: 19
Study 30967135 — intervention group
Group type: COMPARATOR
Intervention: No compression stockings (NCS)
Number of subjects: 19
Study 26628317 — intervention group
Group type: EXPERIMENTAL
Intervention: One-handed chest compression (OHCC) with a 30:2 compression-to-ventilation ratio
Number of subjects: 50
Study 26628317 — intervention group
Group type: COMPARATOR
Intervention: Two-handed chest compression
Number of subjects: 50
Study 26628317 — intervention group
Group type: COMPARATOR
Intervention: Alternating compression hands every other cycle
Number of subjects: 50
Study 25895520 — intervention group
Group type: COMPARATOR
Intervention: Suprasensory SNS
Number of subjects: 59
Study 25895520 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 59
Study 25895520 — intervention group
Group type: COMPARATOR
Intervention: Subsensory SNS
Number of subjects: 59
Study 25895520 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life (QoL; SF36)
Number of subjects: 59
Study 23053764 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-short-course chemotherapy (2SHRZ/XHRZ) for an average duration of 4.5 months
Number of subjects: 185
Study 23053764 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy for an average duration of 9 months
Number of subjects: 185
Study 23053764 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-short-course chemotherapy
Number of subjects: 185
Study 21739205 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional tonsillectomy with bipolar diathermy coagulation
Number of subjects: 100
Study 21739205 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency tonsillectomy
Number of subjects: 100
Study 19489966 — intervention group
Group type: EXPERIMENTAL
Intervention: Metvix cream
Number of subjects: 80
Study 19489966 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 80
Study 16728551 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone therapy (200 mg i.m. every 2 weeks for 3 months)
Number of subjects: 24
Study 16728551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 15327915 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular cola (710 ml, 24 oz)
Number of subjects: 32
Study 15327915 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-free raspberry cookies (87 g, 3 oz)
Number of subjects: 32